CASEY SCURLOCK: Open Payments
NPI 1699414573 · NEW ALBANY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$871 in 43 payments from 27 companies in 2025. Trend: 2023 $418 · 2024 $974 · 2025 $871
Food & beverage: $871
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Astellas Pharma US Inc | 2 | $55 |
| PFIZER INC. | 3 | $52 |
| Corium, LLC | 3 | $47 |
| Amgen Inc. | 2 | $43 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| Verona Pharma, Inc. | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Lundbeck LLC | 2 | $39 |
Products named: CAPLYTA, REXULTI, Veozah, Azstarys, UBRELVY, Qelbree, Ohtuvayre, FREESTYLE LIBRE 3.
Industry payments across OH — which companies pay providers there.
